US-UK Pharma Deal: NHS Costs & Risks
US Deal UK Pharma Market: Expert Warnings on Hidden Risks to NHS Access and Costs Zero Tariffs Boost Exports: UK pharma firms gain tariff-free access to the US market, protecting £6.6 billion in annual exports and sparking investment. NHS Faces £3 Billion Hit: A 25% rise in spending on new drugs could strain budgets, forcing […]
US-UK Pharma Deal: NHS Costs & Risks Read More »